Bayer applies for EU registration for a drug to relieve menopause symptoms
Bayer on Tuesday said it has applied to the European Medicines Agency (EMA) for marketing authorisation for its menopause symptom relief drug elinzanetant. A third late-stage study has shown that taking the pills daily alleviates hot flashes, providing supporting data on efficacy and long-term safety.
POPULAR POSTS
Xavier Dolan is officially returning to film
October 16, 2024
Taylor Swift to release ‘Tortured Poets’ on vinyl and CD
October 16, 2024
UnitedHealth’s medical spending rose sharply in the third quarter
October 16, 2024
LIVE STREAM